Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
SARS-CoV-2 infection and the resulting COVID-19 have afflicted millions of people in an ongoing worldwide pandemic. Safe and effective vaccination is needed urgently to protect not only the general population but also vulnerable subjects such as patients with cancer. Currently approved mRNA-based SA...
Saved in:
| Main Authors: | Emanuela Romano, Patrick Ott, Steve Pascolo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/6/e002932.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA Vaccines Against Infectious Diseases and Cancer
by: Alexander Meisel, et al.
Published: (2021-10-01) -
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01) -
De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis
by: Tamara Davidovic, et al.
Published: (2021-01-01) -
Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients
by: Amanda Bermejo-Gómez, et al.
Published: (2025-01-01) -
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review
by: Michelle Bachmann, et al.
Published: (2025-02-01)